RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 55 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,139 | -85.7% | 1,100 | -81.3% | 0.00% | – |
| Q3 2020 | $127,000 | -87.8% | 5,891 | -84.4% | 0.00% | -100.0% |
| Q1 2019 | $1,037,000 | +11.6% | 37,754 | +9.2% | 0.00% | 0.0% |
| Q4 2018 | $929,000 | -15.5% | 34,562 | -8.2% | 0.00% | 0.0% |
| Q3 2018 | $1,099,000 | -40.3% | 37,660 | -36.1% | 0.00% | -50.0% |
| Q2 2018 | $1,841,000 | +37.2% | 58,903 | -12.6% | 0.00% | +100.0% |
| Q1 2018 | $1,342,000 | – | 67,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |